{"id":"https://openalex.org/W3045197924","doi":"https://doi.org/10.1111/imj.14993","title":"Fixed\u2010dose three\u2010factor prothrombin complex concentrates is safe and effective in warfarin reversal","display_name":"Fixed\u2010dose three\u2010factor prothrombin complex concentrates is safe and effective in warfarin reversal","publication_year":2020,"publication_date":"2020-07-20","ids":{"openalex":"https://openalex.org/W3045197924","doi":"https://doi.org/10.1111/imj.14993","mag":"3045197924","pmid":"https://pubmed.ncbi.nlm.nih.gov/32687237"},"language":"en","primary_location":{"id":"doi:10.1111/imj.14993","doi":"https://doi.org/10.1111/imj.14993","is_oa":false,"landing_page_url":"https://doi.org/10.1111/imj.14993","pdf_url":null,"source":{"id":"https://openalex.org/S60716783","display_name":"Internal Medicine Journal","issn_l":"1444-0903","issn":["1444-0903","1445-5994"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Internal Medicine Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007063064","display_name":"Kirsty Ann Louise Marshall","orcid":"https://orcid.org/0000-0002-3373-9392","observed_orcids":["https://orcid.org/0000-0002-3373-9392"]},"institutions":[{"id":"https://openalex.org/I4210100373","display_name":"Waitemata District Health Board","ror":"https://ror.org/0113yba25","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I4210100373","https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Kirsty Marshall","raw_affiliation_strings":["Department of Haematology, Waitemata District Health Board, Auckland, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, Waitemata District Health Board, Auckland, New Zealand","institution_ids":["https://openalex.org/I4210100373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009932128","display_name":"Eileen Merriman","orcid":"https://orcid.org/0000-0003-2234-4982","observed_orcids":["https://orcid.org/0000-0003-2234-4982"]},"institutions":[{"id":"https://openalex.org/I4210100373","display_name":"Waitemata District Health Board","ror":"https://ror.org/0113yba25","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I4210100373","https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Eileen Merriman","raw_affiliation_strings":["Department of Haematology, Waitemata District Health Board, Auckland, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, Waitemata District Health Board, Auckland, New Zealand","institution_ids":["https://openalex.org/I4210100373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112933431","display_name":"Merit Hanna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100373","display_name":"Waitemata District Health Board","ror":"https://ror.org/0113yba25","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I4210100373","https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Merit Hanna","raw_affiliation_strings":["Department of Haematology, Waitemata District Health Board, Auckland, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, Waitemata District Health Board, Auckland, New Zealand","institution_ids":["https://openalex.org/I4210100373"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052352324","display_name":"Henry Siu Him Chan","orcid":"https://orcid.org/0000-0002-0156-4655","observed_orcids":["https://orcid.org/0000-0002-0156-4655"]},"institutions":[{"id":"https://openalex.org/I4210100373","display_name":"Waitemata District Health Board","ror":"https://ror.org/0113yba25","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I4210100373","https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":true,"raw_author_name":"Henry Chan","raw_affiliation_strings":["Department of Haematology, Waitemata District Health Board, Auckland, New Zealand"],"raw_orcid":"https://orcid.org/0000-0002-0156-4655","affiliations":[{"raw_affiliation_string":"Department of Haematology, Waitemata District Health Board, Auckland, New Zealand","institution_ids":["https://openalex.org/I4210100373"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5052352324"],"corresponding_institution_ids":["https://openalex.org/I4210100373"],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.3274,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.5459259,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"51","issue":"11","first_page":"1884","last_page":"1890"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.9063000082969666,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.9063000082969666,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11116","display_name":"Trauma, Hemostasis, Coagulopathy, Resuscitation","score":0.04190000146627426,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.019700000062584877,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prothrombin-complex-concentrate","display_name":"prothrombin complex concentrate","score":0.9010000228881836},{"id":"https://openalex.org/keywords/warfarin-reversal","display_name":"warfarin reversal","score":0.9390000104904175},{"id":"https://openalex.org/keywords/fixed-dose-dosing","display_name":"fixed-dose dosing","score":0.8889999985694885},{"id":"https://openalex.org/keywords/international-normalized-ratio","display_name":"international normalized ratio","score":0.878000020980835},{"id":"https://openalex.org/keywords/hemorrhage","display_name":"hemorrhage","score":0.8330000042915344},{"id":"https://openalex.org/keywords/thrombosis","display_name":"thrombosis","score":0.7839999794960022},{"id":"https://openalex.org/keywords/anticoagulation-reversal","display_name":"anticoagulant reversal","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9746534824371338},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.815993070602417},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.6211938261985779},{"id":"https://openalex.org/C162156334","wikidata":"https://www.wikidata.org/wiki/Q473420","display_name":"Dose","level":2,"score":0.5956811308860779},{"id":"https://openalex.org/C2777091921","wikidata":"https://www.wikidata.org/wiki/Q2044524","display_name":"Prothrombin complex concentrate","level":4,"score":0.5887429714202881},{"id":"https://openalex.org/C81182388","wikidata":"https://www.wikidata.org/wiki/Q353963","display_name":"Complication","level":2,"score":0.5356279015541077},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5278838872909546},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.500798225402832},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35280168056488037},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.34245216846466064},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.09058356285095215}],"mesh":[{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001779","descriptor_name":"Blood Coagulation Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019934","descriptor_name":"International Normalized Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/imj.14993","doi":"https://doi.org/10.1111/imj.14993","is_oa":false,"landing_page_url":"https://doi.org/10.1111/imj.14993","pdf_url":null,"source":{"id":"https://openalex.org/S60716783","display_name":"Internal Medicine Journal","issn_l":"1444-0903","issn":["1444-0903","1445-5994"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Internal Medicine Journal","raw_type":"journal-article"},{"id":"pmid:32687237","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32687237","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Internal medicine journal","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1641010614","https://openalex.org/W1963901321","https://openalex.org/W1973392179","https://openalex.org/W1980390900","https://openalex.org/W1999235052","https://openalex.org/W2044564909","https://openalex.org/W2045644486","https://openalex.org/W2058821379","https://openalex.org/W2069579366","https://openalex.org/W2108988937","https://openalex.org/W2110167268","https://openalex.org/W2125650394","https://openalex.org/W2152623033","https://openalex.org/W2157559829","https://openalex.org/W2161369674","https://openalex.org/W2323559086","https://openalex.org/W2323709176","https://openalex.org/W2736768859","https://openalex.org/W2741169238","https://openalex.org/W2813643485","https://openalex.org/W2890038263","https://openalex.org/W2902233584","https://openalex.org/W2914139667"],"related_works":["https://openalex.org/W7164314087","https://openalex.org/W3111492533","https://openalex.org/W3173579992","https://openalex.org/W1641010614","https://openalex.org/W3040077716","https://openalex.org/W2220105425","https://openalex.org/W4394009940","https://openalex.org/W104778587","https://openalex.org/W2790491859","https://openalex.org/W2770806583"],"abstract_inverted_index":{"BACKGROUND:":[0],"Reversal":[1],"of":[2,13,39,50,83,106,112,159,180,186,209,240],"warfarin":[3,62,132,244],"with":[4,33,117],"prothrombin":[5],"complex":[6],"concentrates":[7],"(PCC)":[8],"is":[9,24,30,42,59],"required":[10,197],"in":[11,53,203,221,246,251],"cases":[12],"significant":[14,219],"bleeding":[15],"or":[16],"need":[17],"for":[18,61,131,243],"urgent":[19],"surgery.":[20],"A":[21,96,157],"weight-based":[22],"regimen":[23],"commonly,":[25],"but":[26],"a":[27,110,183,198,247,252],"fixed-dose":[28,57,241],"approach":[29],"also":[31,100],"feasible":[32],"clinically":[34],"equivalent":[35],"outcomes.":[36],"The":[37,65,77,164],"purpose":[38],"this":[40],"audit":[41],"to":[43,69,102,174],"review":[44],"the":[45,71,81,104,222,238],"clinical":[46,249],"and":[47,88,94,137,143,147,190,214,224,231],"laboratory":[48],"outcomes":[49,105,226],"patients":[51,84,161,181,196],"treated":[52],"our":[54],"centre":[55],"where":[56],"PCC":[58,87,130,148,242],"used":[60],"reversal.":[63],"AIMS:":[64],"primary":[66,223],"objective":[67],"was":[68,99,168],"evaluate":[70],"post-reversal":[72,184],"international":[73],"normalised":[74],"ratio":[75],"(INR).":[76],"secondary":[78,225],"objectives":[79],"were":[80,141,150,162,227],"proportion":[82],"requiring":[85],"repeat":[86,199],"30-day":[89],"complication":[90],"rates":[91],"(death,":[92],"haemorrhage":[93],"thrombosis).":[95],"subgroup":[97],"analysis":[98],"performed":[101],"compare":[103],"those":[107,118],"who":[108,119,127],"received":[109,120,128],"dose":[111],"\u226415":[113],"IU/kg":[114,122],"(reduced":[115],"dose)":[116],">15":[121],"(standard":[123],"dose).":[124],"METHODS:":[125],"Patients":[126],"three-factor":[129],"reversal":[133,245],"between":[134,229],"1":[135],"January":[136],"31":[138],"December":[139],"2016":[140],"identified":[142],"analysed.":[144,163],"Clinical":[145],"data":[146],"dosages":[149],"extracted":[151],"from":[152],"electronic":[153],"patient":[154],"records.":[155],"RESULTS:":[156],"total":[158],"144":[160],"median":[165],"INR":[166,185],"pre-reversal":[167],"3.25":[169],"(range":[170],"1.4-10),":[171],"which":[172,207],"reduced":[173],"1.5":[175],"(0.9-3.0)":[176],"post-reversal.":[177],"Eighty-seven":[178],"percent":[179],"achieved":[182],"less":[187,192],"than":[188,193],"2":[189,215],"55%":[191],"1.5.":[194],"Sixteen":[195],"dose.":[200],"Complications":[201],"occurred":[202],"22":[204],"(15.3%)":[205],"patients,":[206],"consisted":[208],"15":[210],"deaths,":[211],"7":[212],"thrombosis":[213],"haemorrhage.":[216],"No":[217],"statistically":[218],"differences":[220],"noted":[228],"reduced-dose":[230],"standard-dose":[232],"subgroups.":[233],"CONCLUSION:":[234],"Our":[235],"results":[236],"support":[237],"use":[239],"day-to-day":[248],"practice":[250],"hospital":[253],"setting.":[254]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-07-29T00:00:00"}